Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.
Psychol Med. 2023 Jun;53(8):3661-3671. doi: 10.1017/S0033291722000319. Epub 2022 Mar 8.
Acceptability is an important factor for predicting intervention use and potential treatment outcomes in psychosocial interventions. Cognitive remediation (CR) improves cognition and functioning in people with a diagnosis of schizophrenia, but its acceptability, and the impact of participants and treatment characteristics, remain to be investigated. Few studies provide a direct measure of acceptability, but treatment drop-out rates are often available and represent a valid surrogate.
The systematic search conducted for the most comprehensive CR outcomes database for schizophrenia was updated in December 2020. Eligible studies were randomized clinical trials comparing CR with any other control condition in patients diagnosed with schizophrenia spectrum disorders and that also reported drop-out in treatment and control arms separately. Acceptability was measured as odd-ratios (OR) of drop-out.
Of 2119 identified reports, 151 studies, reporting 169 comparisons between CR and control interventions with 10 477 participants were included in the analyses. The overall rate of drop-out was 16.58% for CR programs and 15.21% for control conditions. In the meta-analysis, no difference emerged between CR interventions and controls [OR 1.10, 95% confidence interval (CI) 0.96-1.25, = 0.177]. Factors improving acceptability were: inpatient only recruitment, participants with fewer years of education and lower premorbid IQ, the presence of all CR core elements, and the presence of techniques to transfer cognitive gains into real-world functioning.
CR for people diagnosed with schizophrenia is effective and has a good acceptability profile, similar to that of other evidence-based psychosocial interventions.
可接受性是预测心理社会干预措施使用和潜在治疗效果的一个重要因素。认知矫正(CR)可改善精神分裂症患者的认知和功能,但参与者和治疗特征的可接受性及其影响仍有待研究。很少有研究提供可接受性的直接衡量标准,但治疗脱落率通常可用,且是一个有效的替代指标。
对精神分裂症最全面的 CR 结果数据库进行了系统检索,该检索于 2020 年 12 月进行了更新。合格的研究为随机临床试验,比较了 CR 与任何其他对照条件在被诊断为精神分裂症谱系障碍的患者中的疗效,且还分别报告了治疗和对照臂的脱落情况。可接受性的衡量标准为脱落的比值比(OR)。
在 2119 篇鉴定报告中,有 151 项研究,涉及 10477 名参与者,对 CR 与对照干预措施进行了 169 项比较,被纳入分析。CR 方案的总体脱落率为 16.58%,对照条件的脱落率为 15.21%。荟萃分析显示,CR 干预措施与对照组之间无差异[OR 1.10,95%置信区间(CI)0.96-1.25, = 0.177]。提高可接受性的因素包括:仅招募住院患者、受教育程度较低和初始智商较低的患者、存在所有 CR 核心要素以及存在将认知收益转移到现实生活功能的技术。
针对精神分裂症患者的 CR 是有效的,且具有良好的可接受性,与其他循证心理社会干预措施相似。